West Announces Participation in Upcoming Investor Conference

West Pharmaceutical Services, traded under the ticker WST, will present virtually at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 24, 2021, at 10:00 AM ET.

Rhea-AI Summary

West Pharmaceutical Services, traded under the ticker WST, will present virtually at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 24, 2021, at 10:00 AM ET. The presentation will be accessible via a live audio webcast on their website. West is known for providing high-quality injectable solutions and services, boasting nearly 10,000 employees and generating over $2.15 billion in sales in 2020. The company is headquartered in Exton, Pennsylvania, and is included in the Standard & Poor's 500 index.

Argus Session date unavailable

+0.15% session move Open Argus

Details

News Market Reaction – WST

The recorded move for WST in the trading session of this news was +0.15%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EXTON, Pa., March 17, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that management will present virtually at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum at 10:00 AM ET on Wednesday, March 24, 2021. 

A live audio webcast of the presentation and a copy of the presentation will be accessible from the Company's website at www.westpharma.com/en/investors.

About West

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 40 billion components and devices each year.

Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2020 generated over $2.15 billion in sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit https://www.westpharma.com/.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

View original content to download multimedia:http://www.prnewswire.com/news-releases/west-announces-participation-in-upcoming-investor-conference-301248897.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will West Pharmaceutical Services present at the KeyBanc Investor Forum?

West Pharmaceutical Services will present on March 24, 2021, at 10:00 AM ET.

How can I access the West Pharmaceutical Services presentation?

The presentation can be accessed through a live audio webcast on West's investor website.

What does West Pharmaceutical Services do?

West provides innovative, high-quality injectable solutions and services for drug developers.

What are the recent sales figures for West Pharmaceutical Services?

In fiscal year 2020, West generated over $2.15 billion in sales.

Where is West Pharmaceutical Services headquartered?

West Pharmaceutical Services is headquartered in Exton, Pennsylvania.

Is West Pharmaceutical Services listed on the stock exchange?

Yes, West is traded on the New York Stock Exchange under the ticker symbol WST.